How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access-Reference-Cited by-同舟云学术

How to achieve full prophylaxis in young boys with severe haemophilia A: different regimens and their effect on early bleeding and venous access

Published:2015-01-13 Issue:4 Volume:21 Page:444-450
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Nijdam A.¹,Kurnik K.²,Liesner R.³,Ljung R.⁴,Nolan B.⁵,Petrini P.⁶,Fischer K.¹⁷,

Affiliation:

1. Van Creveldkliniek; University Medical Center; Utrecht The Netherlands

2. Dr. von Haunersches Children's Hospital; University of Munich; Munich Germany

3. Haemophilia Center; Department of Haematology; Great Ormond Street Hospital for Children; London UK

4. Department of Clinical Sciences Lund - Paediatrics and Malmö Haemostasis & Thrombosis Centre; Lund University; Skåne University Hospital; Malmö Sweden

5. Department of Haematology Oncology; Our Lady's Children's Hospital; Crumlin Dublin Ireland

6. Paediatric Department of Coagulation Disorders; Karolinska University Hospital; Stockholm Sweden

7. Julius Center for Health Sciences and Primary Care; University Medical Center; Utrecht The Netherlands

Funder

Bayer Healthcare

Baxter Healthcare Cooperation

Novo Nordisk

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12613/fullpdf

Reference25 articles.

1. Changes in treatment strategies for severe haemophilia over the last 3 decades: effects on clotting factor consumption and arthropathy;Fischer;Haemophilia,2001

2. Haemophilia prophylaxis in young patients - a long-term follow-up;Lofqvist;J Intern Med,1997

3. Thirty years of hemophilia treatment in the Netherlands, 1972-2001;Plug;Blood,2004

4. Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized;Astermark;Br J Haematol,1999

5. What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?;Petrini;Haemophilia,2001

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art;Bleeding, Thrombosis and Vascular Biology;2024-09-04

2. Bleeding control improves after switching to emicizumab: Real‐world experience of 177 children in the PedNet registry;Haemophilia;2024-04-05

3. The frequency of complications in a cohort of patients diagnosed with hemophilia A and hemophilia B receiving prophylactic treatment in Colombia: A retrospective noninterventional study;PLOS ONE;2023-11-27

4. Considerations for shared decision management in previously untreated patients with hemophilia A or B;Therapeutic Advances in Hematology;2023-01

5. Primary prophylaxis in children with severe haemophilia A and B—Implementation over the last 20 years as illustrated in real‐world data in the PedNet cohorts;Haemophilia;2022-12-26